Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

HAYWARD, Calif., May 13, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st, 2013.

First Quarter 2013 Financial Results:

Loss from operations, which included a non-recurring and non-cash charge of approximately $1.5 million in stock-based compensation, was $6.9 million for the first quarter of 2013, compared to $20.1 million for the first quarter of 2012.  The decrease in loss from operations primarily resulted from a decrease in research and development expenses to $4.9 million from $17.7 million and a decrease in general and administrative expenses from $2.3 million to $2.0 million.  The decrease in research and development expenses in the first quarter of 2013 compared to the first quarter of 2012 was primarily the result of decreased direct and indirect clinical study costs as the Company focuses on the development of blisibimod for systemic lupus erythematosus, or lupus, and IgA nephropathy, an orphan disease.  The Company also experienced lower manufacturing spending as manufacturing of blisibimod for patient dosing in the on-going clinical studies was completed in 2012.  The decrease in general and administrative expenses for the first quarter of 2013 compared to the first quarter of 2012 was primarily due to reduced spending on consulting and professional services and reflects the Company's ongoing cost reduction efforts.

Net loss for the quarter ended March 31, 2013 was $7.6 million, or $0.06 loss per basic and diluted share, compared with loss of $20.9 million, or $0.51 loss per basic and diluted share for the quarter ended March 31, 2012. The decrease in net loss per basic and diluted share in the first quarter of 2013 as compared to the first quarter of 2012 was primarily the result
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 International Isotopes Inc. (OTCQB: ... year ended December 31, 2014.  The Company reports a ... loss, and positive cash flow for the year ended ... in 2014 was approximately $7.5 million compared to approximately ... approximately 10%.  With the exception of the radiological services ...
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Glucose Clamp Study. The study will be performed at ... San Antonio and University Health System,s ... Ralph DeFronzo . The glucose clamp is ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0324750/Virtual-Pharma.html ... in the pharmaceutical market has slowed – almost to a ... cutting costs in a faltering world economy. ...
... NEW YORK, Nov. 3, 2010 Pfizer Inc. (NYSE: ... public to view and listen to a webcast of ... Primary Care, at the 2010 Annual Credit Suisse Healthcare ... Mountain Standard Time. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Reportlinker Adds Virtual Pharma 2Reportlinker Adds Virtual Pharma 3Reportlinker Adds Virtual Pharma 4Reportlinker Adds Virtual Pharma 5Reportlinker Adds Virtual Pharma 6
(Date:4/1/2015)... 2015 ScooterDirect.com is a one stop ... improve their customers’ lifestyle using electric mobility scooters, power ... needs of the people, they provide mobility scooters at ... independent and enjoy their freedom. Scooterdirect.com is offering Pride ... prices. , One of the team members ...
(Date:4/1/2015)... April 01, 2015 Patients with inoperable ... to them, thanks to the FDA’s approval of CRS-207’s ... the full story on the Surviving Mesothelioma website. ... a modified version of the bacteria that causes the ... its manufacturer grant funding and other incentives to support ...
(Date:4/1/2015)... Denver, Colorado (PRWEB) April 01, 2015 ... a member of the American Cannabis Exchange and will ... ACE Marketplace. Native Roots joins the exchange as one ... holding sixty-eight licenses and operating fifteen stores in 9 ... 2015. , “We are excited to have ...
(Date:4/1/2015)... Mateo, CA (PRWEB) April 01, 2015 ... $100,200 in athletics grants from California Casualty . ... free or reduced-cost lunches and subsequently have fewer and ... is named after California Casualty Chairman Emeritus Thomas R. ... field translated to the classroom. Since its inception ...
(Date:4/1/2015)... 01, 2015 The dearth of ... are set to retire in the next five ... demand for laboratory automation. The application of advanced ... it ensures timely progress and efficiency with minimal ... lab automation in high-throughput screening, combinatorial chemistry, automated ...
Breaking Medicine News(10 mins):Health News:ScooterDirect.com Offering Pride Go Go Traveller Elite 3 Wheel Scooter 2Health News:Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 4Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 5Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 2Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 3
... May 18 ... USNA ) launched a nationwide geocaching event ... Energy (TM). Rev3 is a tea-based beverage, containing antioxidants ... lift. To view the Multimedia News Release, go to: ...
... -- ACORN CRO, an oncology-focused CRO, has developed ... The introduction of this dedicated technology tool will speed ... feasibility process. "STAR was developed under the guidance of ... valuable time during the study start-up phase. The resulting ...
... 18 Bell Environmental Services (BES) , a ... area, is offering a travel bed bug kit to ... this summer, business travelers and anyone traveling away from ... Bed Bug Kit contains a 6 ounce bed ...
... May 18 AtlantaNAP ( www.atlantanap.com ... client, Health Information Designs.As a strategic initiative to consolidate ... a need for a true Tier III facility, Health ... data center facility for its core operations. The ...
... and Washinton DC (18 May 2009) Research published this ... estimate the annual costs of autism spectrum disorder (ASD) to ... supporting children with ASDs were estimated to be 2.7 billion ... will be presented at the Autism & Employment Workshop taking ...
... Product to Shift Employees to HSA Plans and Cut CostsAMHERST, ... low-cost, customizable platform for employee HSA education. StreetWise HSA ... transition their employees to Health Savings Account plans and cut ... platform that:, , ...
Cached Medicine News:Health News:Photos: USANA Launches National Rev3 Geocaching Challenge 2Health News:ACORN CRO Launches STAR (Site Tracking and Recruitment) 2Health News:Travel Bed Bug Kit Available for 2009 Summer Travel Season 2Health News:GNAX/AtlantaNAP Announces Newest Client, Health Information Designs 2Health News:Autism in the UK costs more than $41 billion every year, shows new research 2Health News:Autism in the UK costs more than $41 billion every year, shows new research 3Health News:StreetWise HSA(SM) Launched Nationally: First Low-Cost, Customizable Platform for Employee HSA Education 2
... Padgett's commitment to quality and innovation ... new product developments: The Model C is ... precision required for instruments in burn care ... been constructed with the same dedication to ...
Hand surgery basic instrument set with round handled instruments...
Castroviejo caliper...
Rhoton microscopic forceps, straight...
Medicine Products: